Business Description
Neuca SA
ISIN : PLTRFRM00018
Total Employee Number:
4,738Compare
Compare
Traded in other countries / regions
NEU.Poland7HD.Germany0MJR.UK IPO Date
2004-11-22Description
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | 0.19 | |||||
Debt-to-Equity | 0.51 | |||||
Debt-to-EBITDA | 1.43 | |||||
Interest Coverage | 5.6 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.9 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.7 | |||||
3-Year EBITDA Growth Rate | 3.9 | |||||
3-Year EPS without NRI Growth Rate | 8.1 | |||||
3-Year FCF Growth Rate | 18.6 | |||||
3-Year Book Growth Rate | 5.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 22.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.09 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 68.02 | |||||
9-Day RSI | 62.14 | |||||
14-Day RSI | 57 | |||||
3-1 Month Momentum % | -0.69 | |||||
6-1 Month Momentum % | -12.2 | |||||
12-1 Month Momentum % | 6.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.9 | |||||
Quick Ratio | 0.5 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 49.21 | |||||
Days Sales Outstanding | 52.59 | |||||
Days Payable | 107.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.46 | |||||
Dividend Payout Ratio | 0.36 | |||||
3-Year Dividend Growth Rate | 11.6 | |||||
Forward Dividend Yield % | 2.46 | |||||
5-Year Yield-on-Cost % | 4.55 | |||||
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | 1.31 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 11.53 | |||||
Operating Margin % | 2.29 | |||||
Net Margin % | 1.27 | |||||
EBITDA Margin % | 2.97 | |||||
FCF Margin % | 2.26 | |||||
OCF Margin % | 3.19 | |||||
ROE % | 16.18 | |||||
ROA % | 2.99 | |||||
ROIC % | 8.98 | |||||
3-Year ROIIC % | 4.72 | |||||
ROC (Joel Greenblatt) % | 39.34 | |||||
ROCE % | 17.59 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.01 | |||||
Forward PE Ratio | 15.19 | |||||
PE Ratio without NRI | 16.34 | |||||
Shiller PE Ratio | 19.18 | |||||
Price-to-Owner-Earnings | 10.62 | |||||
PEG Ratio | 1.88 | |||||
PS Ratio | 0.24 | |||||
PB Ratio | 2.83 | |||||
Price-to-Free-Cash-Flow | 10.65 | |||||
Price-to-Operating-Cash-Flow | 7.56 | |||||
EV-to-EBIT | 13.71 | |||||
EV-to-EBITDA | 9.42 | |||||
EV-to-Revenue | 0.28 | |||||
EV-to-FCF | 12.37 | |||||
Price-to-GF-Value | 0.81 | |||||
Price-to-Projected-FCF | 0.98 | |||||
Price-to-DCF (Earnings Based) | 1.39 | |||||
Price-to-DCF (FCF Based) | 0.41 | |||||
Price-to-Median-PS-Value | 0.89 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.87 | |||||
Earnings Yield (Greenblatt) % | 7.29 | |||||
FCF Yield % | 9.6 | |||||
Forward Rate of Return (Yacktman) % | 14.82 |
Neuca SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neuca SA Stock Events
| Event | Date | Price (zł) | ||
|---|---|---|---|---|
| PLN 17.800000 Cash Dividend | 2026-06-29 | 718.00 (+0.42%) | ||
| PLN 16.000000 Cash Dividend | 2025-07-15 | 684.00 (-0.15%) |
Show
Entries
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Neuca SA
No articles.